Inflammatix
  • TriVerity
  • Education
    • Acute Infection & Sepsis
    • Immune Response
    • Machine Learning
    • Advocacy
  • Evidence
    • Publications
    • Abstracts
  • Pipeline
  • News
    • News
    • Press Releases
    • ML Blogs
    • Podcasts
    • Media Contact
  • Careers
  • About
    • Leadership
    • Investors
    • Partner With Us
    • Awards
    • Certificates
  • Reach Out
Select Page

Newsroom

Inflammatix in the news

Interview with Tim Sweeney, MD, PhD, Co-Founder of Inflammatix (begins @ 19:40)

Interview with Tim Sweeney, MD, PhD, Co-Founder of Inflammatix (begins @ 19:40)

Jul 28, 2015
Recent News
Artificial Intelligence for Clinical Decision Support in Sepsis

Artificial Intelligence for Clinical Decision Support in Sepsis

May 13, 2021
Inflammatix Checks off All the Right Boxes with Investors

Inflammatix Checks off All the Right Boxes with Investors

Mar 19, 2021
Inflammatix nets $102M to advance its immune system tests for infectious diseases

Inflammatix nets $102M to advance its immune system tests for infectious diseases

Mar 16, 2021
Older NewsRecent News
New Technologies Can Step Up Fight Against Antimicrobial Resistance and Sepsis

New Technologies Can Step Up Fight Against Antimicrobial Resistance and Sepsis

Jan 10, 2020

Inflammatix raises $32M, plus a BARDA contract, for its point-of-care infection diagnostics

Jan 10, 2020
Inflammatix Raises $32M in Series C Financing

Inflammatix Raises $32M in Series C Financing

Jan 10, 2020
Genetic platform takes the guesswork out of catching infections

Genetic platform takes the guesswork out of catching infections

Dec 4, 2019
BARDA awards contract to Inflammatix for innovative diagnostic test systems

BARDA awards contract to Inflammatix for innovative diagnostic test systems

Nov 18, 2019
BARDA backs Inflammatix test to improve antibiotic use

BARDA backs Inflammatix test to improve antibiotic use

Nov 15, 2019
Older NewsRecent News

Press releases

Recent Press Releases

Machine learning blogs

Podcasts



Diagnosing Infection with Ljubomir Buturovic from Inflammatix

December 2023



Advances in Sepsis Diagnostics: the HostDx Sepsis Platform

May 2018

Media Contact

[email protected]

© Copyright 2025, Inflammatix, Inc. All Rights Reserved | Terms & Conditions | Privacy & Cookies Statement
Inflammatix, TriVerity, Myrna, RespVerity, and BacVerity are trademarks of Inflammatix, Inc.

  • Follow
  • Follow